Yusuke Enta
A5054282709- Cardiac Valve Diseases and Treatments
- Infective Endocarditis Diagnosis and Management
- Cardiovascular Function and Risk Factors
- Cardiac Imaging and Diagnostics
- Cardiac pacing and defibrillation studies
- Aortic Disease and Treatment Approaches
- Cardiac, Anesthesia and Surgical Outcomes
- Cardiac Structural Anomalies and Repair
- Atrial Fibrillation Management and Outcomes
- Venous Thromboembolism Diagnosis and Management
- Congenital Heart Disease Studies
- Vascular anomalies and interventions
- Mechanical Circulatory Support Devices
- Cardiac and Coronary Surgery Techniques
- Coronary Interventions and Diagnostics
- Peripheral Artery Disease Management
- Vascular Procedures and Complications
- Diagnosis and Treatment of Venous Diseases
- Advanced Measurement and Metrology Techniques
- Optical measurement and interference techniques
- Frailty in Older Adults
- Cardiovascular and Diving-Related Complications
- Cardiac tumors and thrombi
- Dermatologic Treatments and Research
- Aortic aneurysm repair treatments
Sendai Kousei Hospital
2015-2025
Jikei University School of Medicine
2024-2025
Sendai Shakai Hoken Hospital
2023-2024
Cedars-Sinai Smidt Heart Institute
2020-2022
Cedars-Sinai Medical Center
2020-2022
Keio University
2021
The semiquantitative Clinical Frailty Scale (CFS) is a simple tool to assess patients' frailty and has been shown correlate with mortality in elderly patients even when evaluated by nongeriatricians. aim of the current study was determine prognostic value CFS who underwent transcatheter aortic valve replacement.We utilized OCEAN (Optimized Catheter Valvular Intervention) Japanese multicenter registry review data 1215 replacement. Patients were categorized into 5 groups based on stages: 1-3,...
The authors sought to investigate the prevalence, risk factors, and mid-term mortality in Asian patients with prosthesis-patient mismatch (PPM) after transcatheter aortic valve replacement (TAVR).Little information is available on PPM TAVR patients.The included 1,558 enrolled OCEAN-TAVI (Optimized transCathEter vAlvular iNtervention) Japanese multicenter registry from October 2013 July 2016 excluding who died following before discharge. was defined as moderate if ≧0.65 but ≦0.85 cm2/m2, or...
Background Limited data are available about clinical outcomes and residual mitral regurgitation (MR) after transcatheter edge-to-edge repair in the large Asian-Pacific cohort. Methods Results From Optimized Catheter Valvular Intervention (OCEAN-Mitral) registry, a total of 2150 patients (primary cause 34.6%) undergoing were analyzed classified into 3 groups according to MR severity at discharge: 0+/1+, 2+, 3+/4+. The mortality heart failure hospitalization rates 1 year 12.3% 15.0%,...
Renal impairment is associated with poor clinical outcomes in patients cardiovascular diseases. Some studies have revealed the impact of renal on who underwent mitral valve transcatheter edge-to-edge repair (M-TEER). However, limited data are available regarding baseline after M-TEER Asian-Pacific heart failure and severe regurgitation. This study sought to examine effect using a large-scale nationwide registry Japan. A total 2,150 enrolled OCEAN-Mitral (Optimized Catheter Valvular...
Abstract Background and Aims The association between periprocedural change in tricuspid regurgitation (TR) outcomes patients undergoing mitral transcatheter edge-to-edge repair (M-TEER) is unclear. This study aimed to examine the prognostic value of TR before after M-TEER. Methods Patients OCEAN-Mitral registry were divided into four groups according baseline post-procedure echocardiographic assessments: no TR/no (no TR), TR/significant (new-onset significant (normalized (residual TR) (all...
Transcatheter edge-to-edge repair (TEER) is a less invasive treatment for patients with mitral regurgitation (MR). Limited safety and efficacy data of TEER MitraClip, including the fourth-generation (G4) system, in large cohort, are available.This study aimed to summarize initial experience system MR from registry Japan.The OCEAN (Optimized CathEter vAlvular iNtervention)-Mitral Registry an ongoing, prospective, investigator-initiated, multicenter, observational primary secondary undergoing...
Background In patients with sarcoidosis, cardiac involvement is a crucial prognostic factor leading to severe cardiovascular events. Mitral regurgitation (MR) predisposes drug‐refractory heart failure; however, MR in sarcoidosis (CS) has been scarcely investigated and its therapeutic approach remains unclear. This study aimed investigate the clinical impact of transcatheter edge‐to‐edge repair CS. Methods Patients CS‐related ventricular functional were compared those other nonischemic...
The extent of cardiac damage and its association with clinical outcomes in patients undergoing transcatheter edge-to-edge repair (TEER) for degenerative mitral regurgitation remains unclear. This study was aimed to investigate treated TEER outcomes.
Background The Clinical Frailty Scale (CFS) is a useful frailty marker for predicting clinical outcomes in patients undergoing invasive therapy. However, the impact of CFS after transcatheter edge‐to‐edge repair with mitral regurgitation (MR) remains unclear. This study aimed to elucidate association between baseline frail status defined by and or without postprocedural MR ≥2+ (post‐MR ≥2+) repair. Methods Results Based on Japanese multicenter registry (OCEAN [Optimized Catheter Valvular...
Objectives Patients’ backgrounds and clinical outcomes in urgent/emergent/salvage transcatheter aortic valve replacement (Em-TAVR) remain unclear. We investigated patient characteristics the mortality Em-TAVR predictors for need Em-TAVR. Methods consecutively enrolled 1613 patients undergoing TAVR severe stenosis between October 2013 July 2016 from Optimised transCathEter vAlvular interventioN (OCEAN)-transcatheter implantation (TAVI) registry. The urgency was based on European System...
The balloon-expandable SAPIEN 3 (S3) is superior to the older-generation XT (XT) in a lower incidence of paravalvular aortic regurgitation, complication rates and better survival transcatheter valve implantation (TAVI). However, prosthesis-patient mismatch (PPM) more frequently occurs S3 than XT. Further, little information available on PPM after TAVI using Asians. This study aims determine predictors by focusing difference between data from Japanese multicentre registry.From Optimised...
Background Although transcatheter aortic valve replacement ( TAVR ) is the least invasive treatment for patients with symptomatic stenosis, some hesitate to undergo procedure. We investigated clinical impact of delay after patient refusal . Methods and Results used Japanese OCEAN (Optimized Catheter valvular intervention) regsitry data 1542 who underwent Refusal was defined as at 1 time informed consent. Patients were separated into 2 groups: (28/1542, 1.8%) non-refusal (1514/1542, 98.2%)....
Coronary access after transcatheter aortic valve implantation (TAVI) is challenging due to the changes in geometry. The perpendicular (long-axis) view of heart (THV) usually used as primary fluoroscopic angle. However, it does not always provide sufficient information on rotational axis needed for selective coronary ostia engagement. en face (short-axis) from deep right-anterior-oblique cranial position gives us additional about three-dimensional spatial relationship THV and ostia.We present...